Showing 2 posts of 2 posts found.
GSK has announced that in 2024 it intends to start phase 3 trials of a low carbon version of its …
The FDA has released that GSK would be voluntarily recalling close to 600,000 of its Ventolin asthma inhalers across the …
Care Quality Commission appoints Emily Miles as Chief Executive
National survey aims to improve glaucoma care across the UK
Phase 3 trials support expanded use of Dysport for migraine prevention
Roche secures CE Mark for automated latent tuberculosis blood test
ReproNovo Phase 2 fertility study doses first participant